Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Current Assets: 2012-2025

Historic Current Assets for CorMedix (CRMD) over the last 11 years, with Sep 2025 value amounting to $259.5 million.

  • CorMedix's Current Assets rose 254.78% to $259.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $259.5 million, marking a year-over-year increase of 254.78%. This contributed to the annual value of $114.6 million for FY2024, which is N/A change from last year.
  • Per CorMedix's latest filing, its Current Assets stood at $259.5 million for Q3 2025, which was up 4.63% from $248.1 million recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Current Assets peaked at $259.5 million during Q3 2025, and registered a low of $53.2 million during Q2 2024.
  • Its 3-year average for Current Assets is $115.7 million, with a median of $81.1 million in 2023.
  • Per our database at Business Quant, CorMedix's Current Assets declined by 24.75% in 2022 and then surged by 366.32% in 2025.
  • Over the past 5 years, CorMedix's Current Assets (Quarterly) stood at $66.5 million in 2021, then decreased by 10.41% to $59.6 million in 2022, then spiked by 49.27% to $89.1 million in 2023, then dropped by 17.86% to $114.6 million in 2024, then surged by 254.78% to $259.5 million in 2025.
  • Its last three reported values are $259.5 million in Q3 2025, $248.1 million for Q2 2025, and $144.9 million during Q1 2025.